MAPK9 and chronic myelogenous leukemia, BCR-ABL1 positive: We found an increase in the expression of phosphorylated SAPK/JNK as well as phosphorylated c-jun indicating hyper activation of this pathway during CML progression (Figure 5G and corresponding densitometric analysis in Supplementary Information S3R).